{"id":"https://genegraph.clinicalgenome.org/r/d4c29ce2-de96-407c-a035-d9dbdb57371dv1.0","type":"EvidenceStrengthAssertion","dc:description":"NEFL was first gene reported in relation to autosomal dominant Charcot-Marie-Tooth disease in 2000 (Mersiyanova et al., PMID: 10841809). Based on the literature we differentiate between autosomal dominant NEFL CMT (MONDO:0015626), autosomal recessive NEFL CMT (MONDO:0018993). The split curation for autosomal dominant and recessive CMT has been curated separately. Three different variants (stop-gained) that have been reported in 3 probands in 3 publications (PMIDs: 20039262, 29191368, 19158810) are included in this curation. The mechanism of pathogenicity appears to be a loss-of-function due to the lack of NF network development as described in the in-vitro studies. Functional experimental evidence supports NEFL in controls, patients, and animal models (PMIDs: 17881652, 9388258, 28654681, 26383514, 35237613, 9398473, 8468353). In-vitro functional studies for all described variants depict failure of development in NF networks and lack of NF distribution. In summary, NEFL is definitively associated with autosomal recessive axonal Charcot-Marie-Tooth disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d4c29ce2-de96-407c-a035-d9dbdb57371d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2023-01-10T17:54:09.595Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2023-01-10T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9861217d-b657-4c0c-80c5-ba76d21057a6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81a08284-897c-42a1-8828-b0f4b7b37d62","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81a08284-897c-42a1-8828-b0f4b7b37d62_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant is shown to cause neurofilament abnormalities and reduced expression without filamentous organization. Homozygous mutant is self-assembly incompetent in-vitro. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/81a08284-897c-42a1-8828-b0f4b7b37d62_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20039262","allele":{"id":"https://genegraph.clinicalgenome.org/r/328a99b3-a989-4000-824a-7475f37b7234","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006158.5(NEFL):c.628G>T (p.Glu210Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259657"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/9861217d-b657-4c0c-80c5-ba76d21057a6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20039262","rdfs:label":"II-4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/328a99b3-a989-4000-824a-7475f37b7234"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0009830","obo:HP_0002460","obo:HP_0000764"],"previousTesting":false,"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/81a08284-897c-42a1-8828-b0f4b7b37d62_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/29fcda49-39a4-45bf-9c15-2ba45f44cbca_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7be35319-cf83-4b76-a02c-2e665759ff4c","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7be35319-cf83-4b76-a02c-2e665759ff4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158810","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c986fc4-e3c2-4628-a753-44a2b909774b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006158.5(NEFL):c.418G>T (p.Glu140Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA217549"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/29fcda49-39a4-45bf-9c15-2ba45f44cbca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158810","rdfs:label":"1","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c986fc4-e3c2-4628-a753-44a2b909774b"},"detectionMethod":"Denaturing high-performance liquid chromatography analysis ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypes":["obo:HP_0009830","obo:HP_0000764","obo:HP_0002460"],"previousTesting":true,"previousTestingDescription":"Patients with demyelinating and unclassified CMT were all negative on mutation screening for PMP22, MPZ, GJB1, LITAF, EGR2, GDAP1, MTMR2 and PRX. The patients with axonal and unclassified types were negative for MFN2, MPZ, GJB1, HSP27, HSP22 and GARS.","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7be35319-cf83-4b76-a02c-2e665759ff4c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12407ddb-c5bb-4301-aeee-7d835c745a10_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20039262","rdfs:label":"Palestinian family","estimatedLodScore":2.18,"family":{"id":"https://genegraph.clinicalgenome.org/r/12407ddb-c5bb-4301-aeee-7d835c745a10","type":"Family","rdfs:label":"Palestinian family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9861217d-b657-4c0c-80c5-ba76d21057a6"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0000764","obo:HP_0002460","obo:HP_0009830"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9861217d-b657-4c0c-80c5-ba76d21057a6"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/111d5caf-64f6-4fb6-b5eb-efdef4eaca73_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29191368","rdfs:label":"Chinese family","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/111d5caf-64f6-4fb6-b5eb-efdef4eaca73","type":"Family","rdfs:label":"Chinese family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/268da09a-bbef-4bbe-bddf-f95e58f47efe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29191368","rdfs:label":"1","allele":{"id":"https://genegraph.clinicalgenome.org/r/49f718ee-944f-4a14-8c3e-03e484bc3e2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006158.5(NEFL):c.487G>T (p.Glu163Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10654937"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0002460","obo:HP_0000764","obo:HP_0009830"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6d438dd7-68d7-4f15-8371-ef40dbe4cb37_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29191368","allele":{"id":"https://genegraph.clinicalgenome.org/r/49f718ee-944f-4a14-8c3e-03e484bc3e2a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0009830","obo:HP_0000764","obo:HP_0002460"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/268da09a-bbef-4bbe-bddf-f95e58f47efe"}},{"id":"https://genegraph.clinicalgenome.org/r/15bf0a1b-35a8-4ee3-998c-192b748a8022_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158810","rdfs:label":"Japanese family","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/15bf0a1b-35a8-4ee3-998c-192b748a8022","type":"Family","rdfs:label":"Japanese family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/29fcda49-39a4-45bf-9c15-2ba45f44cbca"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002460","obo:HP_0009830","obo:HP_0000764"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/29fcda49-39a4-45bf-9c15-2ba45f44cbca"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/268da09a-bbef-4bbe-bddf-f95e58f47efe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d438dd7-68d7-4f15-8371-ef40dbe4cb37","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d438dd7-68d7-4f15-8371-ef40dbe4cb37_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/268da09a-bbef-4bbe-bddf-f95e58f47efe"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3da179c4-d25b-438f-be58-bff4f02ddc10","type":"EvidenceLine","dc:description":"1 point was given instead of 2 because the model does not use a known variant, it is just a KO. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc5fd206-41e0-4cc1-a030-653fd69f3f82","type":"Finding","dc:description":"Model system shows decreased number of axons, decreased axonal diameter contributing to decreased axonal caliber (seen in humans) and decreased myelin thickness. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9398473","rdfs:label":"KO Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a08008b5-f163-4295-90a4-c6938406fcd6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1b83c2e-0627-454b-8c1a-679d39a0c255","type":"FunctionalAlteration","dc:description":"iPSC-motor neurons lacking NFL form filamentous structures and have reduced axonal caliber.There are still neurofilament-like structures in the motor neurons, but filamentous unorganized structures in the soma and neurites. Decreased axonal area noted in patient p.Arg367X and in KO isogenic controls when compared to wildtype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35237613","rdfs:label":"Decreased axonal caliber in KO-NFL iPSC-MN"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3095155a-be2e-40be-9884-49c8af431137","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a494c104-ba31-4d5e-b68d-b6b59d45cece","type":"FunctionalAlteration","dc:description":"Immunocytochemistry of transfected SW-13 cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20039262","rdfs:label":"Aggregate formation in E210X Variant"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/49d4cf82-b365-456e-9e35-2b28a66b71ec_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35e1ea92-aa82-4b93-998e-4748f9194e31","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e90e4e81-26fe-40e6-a4c2-9847003f4e1e","type":"Finding","dc:description":"Western blot analysis of associations between purified NF subunits in a native page gel. NF subunits were individually purified from rat DRGs and mixed as indicated on figure. NEFH and NEFL proteins are known to interact as axonal cytoskeletal components. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9388258","rdfs:label":"Purified NEFH heterodimerizes with NEFL","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a5983464-14b1-45a2-96d9-2705832e871b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f9abe2d-2394-4eac-918a-789f96b96851","type":"Finding","dc:description":"NEFL co-immunoprecipitates with HSPB1","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17881652","rdfs:label":"NEFL Co-Immunoprecipitates with HSPB1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2c3cf459-7795-4fe1-93b0-e2cddf2bdf68","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d338e3c-f17d-4fa2-b71d-3d35f7af6b90","type":"Finding","dc:description":"Murine model western blot showing stable expression of NEFL in cerebellum, DRG, and spinal cord. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28654681","rdfs:label":"Western Blot of murine nervous system tissue","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cea83cba-db65-4710-ad18-3116581c71b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20059e5b-7e7f-4f96-aa0d-02b045e5264f","type":"Finding","dc:description":"Rat sciatic nerve immunocytochemistry shows abundant expression of NEFL throughout the nerve tissue. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26383514","rdfs:label":"Rat sciatic nerve ICC","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":5751,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Chk8pnnddsQ","type":"GeneValidityProposition","disease":"obo:MONDO_0018993","gene":"hgnc:7739","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_49d4cf82-b365-456e-9e35-2b28a66b71ec-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}